The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterized by an incompletely reversible limitation in airflow. A physiological variable--the forced expiratory volume in one second (FEV1)--is often used to grade the severity of COPD. However, patients with COPD have systemic manifestations that are not reflected by the FEV1. We hypothesized that a multidimensional grading system that assessed the respiratory and systemic expressions of COPD would better categorize and predict outcome in these patients. METHODS: We first evaluated 207 patients and found that four factors predicted the risk of death in this cohort: the body-mass index (B), the degree of airflow obstruction (O) and dyspnea (D), and exercise capacity (E), measured by the six-minute-walk test. We used these variables to construct the BODE index, a multidimensional 10-point scale in which higher scores indicate a higher risk of death. We then prospectively validated the index in a cohort of 625 patients, with death from any cause and from respiratory causes as the outcome variables. RESULTS: There were 25 deaths among the first 207 patients and 162 deaths (26 percent) in the validation cohort. Sixty-one percent of the deaths in the validation cohort were due to respiratory insufficiency, 14 percent to myocardial infarction, 12 percent to lung cancer, and 13 percent to other causes. Patients with higher BODE scores were at higher risk for death; the hazard ratio for death from any cause per one-point increase in the BODE score was 1.34 (95 percent confidence interval, 1.26 to 1.42; P<0.001), and the hazard ratio for death from respiratory causes was 1.62 (95 percent confidence interval, 1.48 to 1.77; P<0.001). The C statistic for the ability of the BODE index to predict the risk of death was larger than that for the FEV1 (0.74 vs. 0.65). CONCLUSIONS: The BODE index, a simple multidimensional grading system, is better than the FEV1 at predicting the risk of death from any cause and from respiratory causes among patients with COPD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The BODE index [BMI, airflow limitation (forced expiratory volume in one second), dyspnea and 6-min walk distance], which has been externally validated in at least 13 additional cohorts following the original derivation. The BODE index has been cited as the prognostic model of choice by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and it formed the basis for listing recommendations in the 2014 ISHLT candidate selection guidelines. (4, 166–168)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [166]
In the citing paper
“Although COPD remains the most common indication for lung transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
In the citing paper
“the BODE score (body mass index, degree of airway obstruction, dyspnea, and exercise capacity score) is still the most important indicator, and along with it, FEV1 and the presence or absence of acute exacerbation determine whether transplantation is possible based on the presence or absence of evidence for pulmonary arterial hypertension (PAH), as summarized in Table 2 [3,42].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [42]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
PAUWELS, R. A., BUIST, A. S., CALVERLEY, P. M. A., JENKINS, C. R., & HURD, S. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2101039 · Cited by 6,587
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Mortality by cause for eight regions of the world: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043
Lung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Evaluation of Clinical Methods for Rating Dyspnea
Mahler, D. A., & Wells, C. K. (1988) · Chest · doi:10.1378/chest.93.3.580 · Cited by 1,822
Research works printed but not linked: 1
- Burrows B, 1991, Eur Respir Rev, 1, 340
Cited by
Items 901–1,000 of 1,007
de Voogd, J. N., Wempe, J. B., Postema, K., van Sonderen, E., Ranchor, A. V., Coyne, J. C., & Sanderman, R. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9105-8 · Cited by 44
“In addition, the BODE index, a multidimensional ten-point scale consisting of graded scores of BMI, airflow obstruction, dyspnea, and exercise capacity is considered a valuable tool for predicting the risk of death in patients with COPD [24, 25].”
Reséndiz-Hernández, J. M., Ambrocio-Ortiz, E., Pérez-Rubio, G., López-Flores, L. A., Abarca‐Rojano, E., Pavón-Romero, G. F., Flores-Trujillo, F., Hernández-Zenteno, R. D. J., Camarena, Á., Pérez‐Rodríguez, M., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s147688 · Cited by 44
“41 In 2012, a study was performed in a Taiwanese population, in which the TNF -863 (rs1800630) was associated with an increased BMI; 42 however, Eagan et al found increased levels of TNF-α were associated with a loss of lean body mass; 43 nevertheless, there are no studies in our population…”
Xie, H., Jiang, Y., Liu, L., Peng, H., Li, J., & Chen, Z. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111537 · Cited by 46
Acceptability and feasibility of pulmonary rehabilitation for COPD: a community qualitative study
Moore, L. J., Hogg, L., & White, P. T. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00086 · Cited by 48
“in the USA found that 53% either declined to take part or dropped out.(12) There is poor understanding of the barriers to and effective facilitators of this treatment.”
BackgroundExercise Training in Pulmonary Rehabilitation
Andrianopoulos, V., Klijn, P. H. C., Franssen, F. M. E., & Spruit, M. A. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.02.013 · Cited by 53
Integrative genomics of chronic obstructive pulmonary disease
Hobbs, B. D., & Hersh, C. P. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.086 · Cited by 47
Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD
Moore, A., Suades, R., Cetti, E. J., Sathyapala, S. A., Hopkinson, N. S., Roughton, M., Moxham, J., & Polkey, M. I. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.03.001 · Cited by 44
Validation of the COPD severity score for use in primary care: the NEREA study
Miravitlles, M., Llor, C., De-Castellar, R., Izquierdo, I., Baro, E., & Donado, E. (2009) · European Respiratory Journal · doi:10.1183/09031936.00087208 · Cited by 44
Obesity and metabolic syndrome in COPD: Is exercise the answer?
James, B., Jones, A., Trethewey, R. E., & Evans, R. A. (2017) · Chronic Respiratory Disease · doi:10.1177/1479972317736294 · Cited by 54
Interdisciplinary COPD intervention in primary care: a cluster randomised controlled trial
Liang, J., Abramson, M. J., Russell, G. M., Holland, A. E., Zwar, N. A., Bonevski, B., Mahal, A. S., Eustace, P., Paul, E. M., Phillips, K., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01530-2018 · Cited by 48
Al‐Mudares, F., Reddick, S. J., Ren, J. L., Venkatesh, A., Zhao, C., & Lingappan, K. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594137 · Cited by 46
“Low body mass index (BMI) is a risk factor for exaggerated decline in the lung function, and is an independent predictor of the overall mortality in COPD (64), and is a bad prognostic indicator in the BODE index; which is used to predict the mortality risk among COPD patients (65).”
BackgroundCo-occurrence of Physical Frailty and COPD and Association With Disability and Mortality
Lee, S. Y., Nyunt, M. S. Z., Gao, Q., Gwee, X., Chua, D. Q. L., Yap, K. B., Wee, S. L., & Ng, T. P. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.12.633 · Cited by 44
Almatrafi, A. A., Thomas, O., Callister, M. E. J., Gabe, R., Beeken, R. J., & Neal, R. D. (2022) · Journal of Medical Screening · doi:10.1177/09691413221117685 · Cited by 46
“The utilisation of functional assessment tools, such as the BODE index,(56) is suggested to be a better way of assessing the severity and fitness of patients with advanced COPD by incorporating not only the degree of airflow obstruction but also functional dyspnea, bodymass index, and exercise capacity.(15,56) We also…”
MethodMACE in COPD: addressing cardiopulmonary risk
Hurst, J. R., Gale, C. P., Hurst, J. R., Bhutani, M., Bourbeau, J., Han, M. K., Hawkins, N. M., Lam, C. S. P., Marciniuk, D. D., Price, D. B., et al. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00038-9 · Cited by 50
van der Veer, T., Andrinopoulou, E., Braunstahl, G., Charbonnier, J. P., Kim, V., Latisenko, R., Lynch, D. A., & Tiddens, H. A. W. M. (2024) · Thorax · doi:10.1136/thorax-2024-221928 · Cited by 49
Bausewein, C., Jolley, C. J., Reilly, C. C., Lobo, P., Kelly, J., Bellas, H., Madan, P., Pannell, C., Brink, E., Biase, C. D., et al. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-58 · Cited by 43
“The distance walked (6 minute walk distance, [6MWD]) has demonstrated strong correlation with peak rate of oxygen uptake, maximum work rate [43] and prognosis in patients with lung cancer [44] and chronic respiratory disease [45].”
BackgroundA longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD
Ko, F. W. S., Tam, W., Tung, A., Ngai, J. C. L., Ng, S. S., Lai, K., Au, K. F., & Hui, D. S. C. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.06.022 · Cited by 43
“Interestingly, the hazard ratio for change of 1 point of the baseline BODE index in relationship to the mortality in this current study was similar to the study by Celli et al.8 It appears that the BODE index is applicable to both the Caucasians and Chinese COPD subjects using the same cutoff values for calculation.”
InfluentialClinical and radiographic correlates of hypoxemia and oxygen therapy in the COPDGene study
Kim, D. K., Jacobson, F. L., Washko, G. R., Casaburi, R. H., Make, B. J., Crapo, J. D., Silverman, E. K., & Hersh, C. P. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.02.015 · Cited by 44
Disler, R. T., Currow, D. C., Phillips, J. L., Smith, T., Johnson, M. J., & Davidson, P. M. (2012) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2012.02.004 · Cited by 47
Clinical characteristics and airway inflammation profile of COPD persistent sputum producers
Khurana, S., Ravi, A., Sutula, J., Milone, R., Williamson, R., Plumb, J., Vestbo, J., & Singh, D. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.09.020 · Cited by 43
Microparticles in sputum of COPD patients: a potential biomarker of the disease?
Porro, C., Lacedonia, D., Carpagnano, G. E., Trotta, T., Palladino, G. P., Panaro, M. A., Zoppo, L., & Barbaro, M. P. F. (2016) · International Journal of COPD · doi:10.2147/copd.s99547 · Cited by 43
Negewo, N. A., Gibson, P. G., Wark, P. A. B., Simpson, J. L., & McDonald, V. M. (2017) · International Journal of COPD · doi:10.2147/copd.s136256 · Cited by 43
“It is interesting to note that participants in our study were taking a higher number of medications compared to ]), 43 and HIV (median 21 [12, 29]) 44 but lower than that reported in hospitalized COPD patients (mean [SD] 35.3 [14.4]) 18 and elderly inpatients ( $ 65 years, mean [SD] 30.3 [14]).”
InfluentialBurkes, R. M., Gassett, A. J., Ceppe, A., Anderson, W. H., O’Neal, W. K., Woodruff, P. G., Krishnan, J. A., Barr, R. G., Han, M. K., Martínez, F. J., et al. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201710-837oc · Cited by 43
Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers
Mason, S., Moreta-Martínez, R., Labaki, W. W., Strand, M. J., Regan, E. A., Bon, J. M., Estépar, R. S. J., Casaburi, R. H., McDonald, M., Rossiter, H. B., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.10.047 · Cited by 44
Shinozuka, N., Tatsumi, K., Nakamura, A., Terada, J., & Kuriyama, T. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01057.x · Cited by 43
“The effect of the systemic manifestations of COPD on the prediction of mortality using a multidimensional index has recently been reported.(2) We investigated the effects of the traditional herbal medicine Hochuekkito (Bu-ZhongYi-Qi-Tang) on systemic inflammation in older patients with COPD whose forced expiratory vol…”
BackgroundIncreased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations
Scott, A., Wang, X., ROAD, J. D., & Reid, W. D. (2005) · European Respiratory Journal · doi:10.1183/09031936.06.00143004 · Cited by 45
Long-term outcomes following first short-term clinically important deterioration in COPD
Naya, I. P., Tombs, L., Muellerova, H., Compton, C., & Jones, P. (2018) · Respiratory Research · doi:10.1186/s12931-018-0928-3 · Cited by 43
Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study
Chin, A. T., Rylance, J., Makumbirofa, S., Meffert, S., Vu, T. A., Clayton, J., Mason, P. R., Woodruff, P. G., & Metcalfe, J. Z. (2019) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.18.0313 · Cited by 43
“0001 Obstruction † 20 (14) 6 (26) Moderate 12 (60) 4 (66) Severe 2 (10) 2 (33) CAT score Absolute scores (Q1 Q3) 7 (4–11) 16 (10–17) <0.”
Hughes, A. D., & Jones, L. H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.106 · Cited by 44
Determinants of exercise capacity in obese and non-obese COPD patients
Rodriguez, D. A., García‐Aymerich, J., Valera, J. L., Sauleda, J., Togores, B., Gáldiz, J. B., Gea, J., Orozco‐Levi, M., Ferrer, A., Gómez, F. P., et al. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.02.004 · Cited by 42
“The 6MWT is increasingly recognized as an important test for clinical assessment and monitoring of COPD patients [32].”
BackgroundReduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease
Minakata, Y., Sugino, A., Kanda, M., Ichikawa, T., Akamatsu, K., Koarai, A., Hirano, T., Nakanishi, M., Sugiura, H., Matsunaga, K., et al. (2013) · Respiratory Investigation · doi:10.1016/j.resinv.2013.06.002 · Cited by 44
“Dyspnea was evaluated with a modified Medical Research Council (MMRC) dyspnea scale [22], and modified BODE (mBODE) index, in which the original 6-min walking test [23] was substituted for the incremental shuttle walking test (point 0: 4350 m; 1: 250–349 m; 2: 150–249 m; and 3: o149 m).”
BackgroundMethodNickler, M., Ottiger, M., Steuer, C., Huber, A., Anderson, J. B., Müller, B., & Schüetz, P. (2015) · Respiratory Research · doi:10.1186/s12931-015-0283-6 · Cited by 43
“Additionally, measurement of ProADM combined with the clinical parameters of body mass index, airflow obstruction, dyspnea and exercise capacity index (BODE) [42] improves the predictive power of medium-term all-cause mortality compared to the use of BODE alone [40].”
MethodGünay, E., Ergün, P., Kaymaz, D., Erdoğan, Y., Turay, �., Demir, N., Çanak, E., Şengül, F., Egesel, N., & Köse, S. K. (2011) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.78420 · Cited by 42
“[1,14] Dyspnea was assessed by MRC and modified BORG dyspnea scales.[8,9,15,16] Exercise capacity was evaluated with ISWT and endurance shuttle walking test (ESWT).”
BackgroundMethodInfluentialLoi, A. T. L. T., Hoonhorst, S. J. M., Franciosi, L., Bischoff, R., Hoffmann, R. F., Heijink, I. H., van Oosterhout, A. J. M., Boezen, H. M., Timens, W., Postma, D. S., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002178 · Cited by 42
“The BODE-index will be calculated on the basis of FEV1, 6 min walking distance (6MWD), body mass index (BMI) and MRC-dyspnoea score.(4) In urine (micro) protein concentration will be assessed.”
BackgroundMethodSlok, A. H. M., Veen, J. C. C. M. I. ’., Chavannes, N. H., van der Molen, T., Mölken, M. R., Kerstjens, H. A. M., Salomé, P. L., Holverda, S., Dekhuijzen, P. R., Schuiten, D., et al. (2014) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2014.21 · Cited by 42
Iguchi, A., Senjyu, H., Hayashi, Y., Kanada, R., Iwai, S., Honda, S., Kitagawa, C., Ozawa, H., & Rikitomi, N. (2012) · Respiratory Care · doi:10.4187/respcare.01844 · Cited by 50
Grogono, J. C., Butler, C., Izadi, H., & Moosavi, S. H. (2018) · Respiratory Research · doi:10.1186/s12931-018-0886-9 · Cited by 42
Pulmonary Rehabilitation in the Management of Chronic Lung Disease
Cornelison, S. D., & Pascual, R. M. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.12.015 · Cited by 42
Assessment of physical functioning in the clinical care of the patient with advanced kidney disease
Roshanravan, B., & Patel, K. V. (2019) · Seminars in Dialysis · doi:10.1111/sdi.12813 · Cited by 46
Unravelling young COPD and pre-COPD in the general population
Cosío, B. G., Casanova, C., Soler‐Cataluña, J. J., Soriano, J. B., Rio, F. G., de Lucas, P., Alfageme, I., González-Moro, J. M. R., Sánchez, G., Ancochea, J., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00334-2022 · Cited by 42
Self-citationLung transplantation for COPD/pulmonary emphysema
Verleden, G. M., & Gottlieb, J. (2023) · European Respiratory Review · doi:10.1183/16000617.0116-2022 · Cited by 45
Donesky, D., Nguyen, H. Q., Paul, S. M., & Carrieri‐Kohlman, V. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.05.019 · Cited by 42
Biomarkers in chronic obstructive pulmonary disease: confusing or useful?
Stockley, R. A. (2014) · International Journal of COPD · doi:10.2147/copd.s42362 · Cited by 42
“11 Because these relatively insensitive tests have been studied for many years, their use in assessing patients’ prognosis, progression, and response to treatment has been well documented.”
Nguyen, H. Q., Donesky, D., & Carrieri‐Kohlman, V. (2007) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2007.09.012 · Cited by 42
“A multidimensional measure of disease severity (BODE Index) was calculated for each subject using a previously described empirical model based on a summary score of body mass index (BMI), airway obstruction, dyspnea, and exercise performance during the 6MW (Celli et al., 2004).”
BackgroundMethodInfluentialTranslating the COPD Transcriptome: Insights into Pathogenesis and Tools for Clinical Management
Zeskind, J. E., Lenburg, M. E., & Spira, A. E. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-074th · Cited by 42
Esteban, C., Quintana, J. M., Moraza, J., Aburto, M., Aguirre, U., Aguirregomoscorta, J. I., Aizpiri, S., Basualdo, L. V., & Capelastegui, A. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-28 · Cited by 44
Rasmussen, T., Køber, L., Pedersen, J. H., Dirksen, A., Thomsen, L. H., Stender, S., Brodersen, J., Groen, H. J. M., Ashraf, H., & Kofoed, K. F. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet057 · Cited by 46
Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor
Barba, R., Sánchez, G. G. D. C., Marco, J. P., Losa, J. E., Plaza, S., Canora, J., & Zapatero, A. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.675318 · Cited by 43
“In the COPD population from which Celli et al.(18) derived the prognostic value of a multi-dimensional index combining four variables (body mass index, airflow obstruction, dyspnea, and exercise capacity [BODE] index), the patients who died had a significantly lower hematocrit (mean SD, 39 5%) than those who survived…”
The Role of Cardiopulmonary Exercise Test in IPF Prognosis
Triantafillidou, C., Manali, E. D., Lyberopoulos, P., Kolilekas, L. F., Kagouridis, K., Gyftopoulos, S., Vougas, K. N., Kotanidou, A. N., Alchanatis, M., Karakatsani, A., et al. (2013) · Pulmonary Medicine · doi:10.1155/2013/514817 · Cited by 44
“The evaluation of multidimensional models of survival, combining variables that independently predict mortality and share common underlying physiologic determinants, has already been studied in respiratory diseases such as COPD [30].”
BackgroundAndrianopoulos, V., Celli, B. R., Franssen, F. M. E., Pinto-Plata, V., Calverley, P. M. A., Vanfleteren, L. E. G. W., Vogiatzis, I., Vestbo, J., Agustí, A. G. N., Bakke, P. S., et al. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.08.023 · Cited by 45
“Moreover, those with EID had higher scores in the ADO [27] and the BODE [28] indices compared to non-EID subjects (Table 2).”
BackgroundMethodResultSelf-citationWilliams, M., Cafarella, P., Olds, T., Petkov, J., & Frith, P. (2010) · Chest · doi:10.1378/chest.09-2498 · Cited by 41
Sharp, C., Adamali, H. I., & Millar, A. B. (2017) · ERJ Open Research · doi:10.1183/23120541.00096-2016 · Cited by 41
COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study
Miravitlles, M., Izquierdo, I., Herrejón, A., Torres, J. V., Baró, E., & Borja, J. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2010.12.020 · Cited by 41
Update on obstructive sleep apnea and its relation to COPD
Ezzie, M. E., & Mieczkowski, B. P. (2014) · International Journal of COPD · doi:10.2147/copd.s42394 · Cited by 46
“A second clinical case involved a 55-year-old post-menopausal female who was an active smoker with moderate COPD.”
InfluentialPlasma metabolomics and clinical predictors of survival differences in COPD patients
Pinto-Plata, V., Casanova, C., Divo, M. J., Tesfaigzi, Y., Calhoun, V. D., Jing Sui (Beijing Normal University), my correct affiliation is beijing normal university, N. Q. U. O. S. A. T., Polverino, F., Priolo, C., Petersen, H. V., de-Torres, J. P., et al. (2019) · Respiratory Research · doi:10.1186/s12931-019-1167-y · Cited by 41
“The severity of airflow limitation and dypsnea and the presence of low body mass index and decrease exercise capacity are known clinical factors able to predict risk of death, especially when integrated into the multidimensional BODE index [4].”
BackgroundMethodSelf-citationMatsunaga, K., Harada, M., Suizu, J., Oishi, K., Asami‐Noyama, M., & Hirano, T. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103078 · Cited by 46
“The association between low body mass index (BMI) and poor prognosis in patients with COPD independently of the ventilation impairment is well known [118,119].”
BackgroundScarlata, S., Finamore, P., Laudisio, A., Cardaci, V., Ramaccia, M., D’Alessandro, F., Pedone, C., Incalzi, R. A., & Cesari, M. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01878-z · Cited by 42
“Adverse outcome is more frequent in patients with a BODE index of 3 or more [9].”
BackgroundMethodInfluentialPhosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
Kawamatawong, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.518345 · Cited by 42
“Body mass index (BMI) is considered the prognostic marker of COPDmortality (Celli et al., 2004).”
BackgroundTakahashi, S., & Betsuyaku, T. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.05.005 · Cited by 42
“[112] Celli BR, Cote CG, Marin JM, et al.”
BackgroundRamsey, S. D., & Hobbs, R. F. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-094ss · Cited by 42
“The body-mass index, airflow obstruction dyspnea, and exercise capacity (BODE) index is a useful step in this direction ( 20 ).”
BackgroundThe concept of control in COPD: a new proposal for optimising therapy
Soler‐Cataluña, J. J., Navarrete, B. A., & Miravitlles, M. (2014) · European Respiratory Journal · doi:10.1183/09031936.00064414 · Cited by 41
Update in Chronic Obstructive Pulmonary Disease 2007
MacNee, W. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-167up · Cited by 51
“The six-minute-walk distance (6MWD) is an important tool in the functional assessment of patients with COPD (33).”
MethodPunekar, Y. S., Riley, J., Lloyd, E., Driessen, M. T., & Singh, S. (2017) · International Journal of COPD · doi:10.2147/copd.s100204 · Cited by 45
“Consequently, a composite measurement assessing several factors reflective of COPD, such as the BODE index, which evaluates a surrogate of nutritional state (body-mass index), airflow obstruction (FEV 1 ), dyspnea (mMRC), and exercise capacity (6MWT), may be a more accurate measure of COPD severity and prognosis.(72)…”
BackgroundNetwork Modules Uncover Mechanisms of Skeletal Muscle Dysfunction in COPD Patients
Tényi, Á., Cano, I., Marabita, F., Kiani, N., Kalko, S. G., Barreiro, E., de Atauri, P., Cascante, M., Gomez-Cabrero, D., & Roca, J. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1405-y · Cited by 40
Body mass index as a predictor of mortality in bronchiectasis: A nationwide population-based study
Lee, J. M., Lee, S. A., Han, C. H., Lee, S. M., Kim, C. J., Lee, S. C., & Park, S. C. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106370 · Cited by 41
Hutchinson, A. F., Brand, C. A., Irving, L. B., Roberts, C., Thompson, P. J., & Campbell, D. A. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02195.x · Cited by 43
Review: Systemic consequences of COPD
Tkáč, J., Man, S. F. P., & Sin, D. D. (2007) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465807082374 · Cited by 52
“These adverse changes in the muscles become exaggerated with hormonal changes (discussed in the previous section), use of corticosteroids, and with poor nutrition [ Casaburi, 2000 ].”
A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease
Menn, P., Leidl, R., & Holle, R. (2012) · PharmacoEconomics · doi:10.2165/11591340-000000000-00000 · Cited by 42
“As in all COPD models published so far, disease stages were categorized according to lung function, and progression was considered in the form of lung function decline only, although COPD is a systemic disease, and measures such as the BODE (Body-mass index, airflow Obstruction, Dyspnea, and Exercise capacity) index([…”
Kocks, J. W. H., Kerstjens, H. A. M., Snijders, S. L., de Vos, B., Biermann, J. J., van Hengel, P., Strijbos, J. H., Bosveld, H. E. P., & van der Molen, T. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-135 · Cited by 40
“The BODE score (a multidimensional index) was calculated[12].”
MethodChronic obstructive pulmonary disease and bronchiectasis
Novosad, S., & Barker, A. F. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835d8312 · Cited by 40
“It has been shown to be better than FEV1 alone at predicting the risk of death in patients with COPD [16].”
BackgroundDyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer
Ban, W. H., Lee, J. M., Ha, J. H., Yeo, C. D., Kang, H. H., Rhee, C. K., Moon, H. S., & Lee, S. H. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.5.1063 · Cited by 40
“Nevertheless, additional prospective study will be needed to delineate the effects of appropriate monitoring and management on patients with lung cancer and COPD.”
BackgroundInfluentialThe Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD
Al-shair, K., Kolsum, U., Singh, D., & Vestbo, J. (2016) · Lung · doi:10.1007/s00408-016-9931-y · Cited by 40
“ATS guideline [11], a cut-point for 6MWD of 350 m was chosen on the basis of the BODE index [29] and its ability to identify poor exercise performance [30].”
MethodSuzuki, M., Muro, S., Fukui, M., ISHIZAKI, N., Satô, S., Shiota, T., Endo, K., Suzuki, T., MITSUMA, T., Mishima, M., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2341-3 · Cited by 43
Patients with Obesity Have Better Long-Term Outcomes after Hospitalization for COPD Exacerbation
DeLapp, D., Glick, C., Furmanek, S. P., Ramírez, J. A., & Cavallazzi, R. (2020) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2020.1781805 · Cited by 41
Huang, Q., He, C., Xiong, H., Shuai, T., Zhang, C., Zhang, M., Wang, Y., Zhu, L., Lü, J., & Liu, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037923 · Cited by 49
“As a specific and easily scored predictor for patients with AECOPD, DECAF scores are superior to other prognostic scores.”
ResultPulmonary Rehabilitation in Non-small Cell Lung Cancer Patients After Completion of Treatment
Glattki, G. P., Manika, Κ., Sichletidis, L. T., Alexe, G., Brenke, R., & Spyratos, D. G. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318209ced7 · Cited by 40
“On the basis of the above measurements BODE (body mass index, FEV1, 6-MWT distance, MMRC dyspnea score) index was calculated as described earlier.(19) Higher scores in BODE index are related with worse prognosis.”
How does cachexia influence survival in cancer, heart failure and other chronic diseases?
Lainscak, M., Podbregar, M., & Anker, S. D. (2007) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e3282f31667 · Cited by 40
Pulmonary rehabilitation in chronic obstructive pulmonary disease
Derom, E., Marchand, É., & Troosters, T. (2007) · Annales de Réadaptation et de Médecine Physique · doi:10.1016/j.annrmp.2007.04.022 · Cited by 47
Prognostication — The lost skill of medicine
Kellett, J. G. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.09.002 · Cited by 46
MAGNUSSEN, H., Watz, H., Kirsten, A., Wang, M., Wray, H., Samuelsson, V., Mo, J., & Kay, R. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.05.003 · Cited by 42
Shah, A. S. M., Anshar, F. M., Faizal, M. P. A., Zaharim, A., Roslina, A. M., & Harun, R. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.052399 · Cited by 43
“introduced and validated a multifactorial grading system that incorporated the body mass index, degree of airflow obstruction, functional dyspnoea and exercise capacity of patients with COPD. The cumulative scores of the BODE index correlated well with mortality.”
BackgroundDefining Disease Modification in Chronic Obstructive Pulmonary Disease
Halpin, D. M. G., & Tashkin, D. P. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550902918402 · Cited by 42
“Numerous factors are reported to influence mortality in COPD including FEV1 (58), dyspnea (59), disease duration (60), carbon dioxide and oxygen arterial tensions (56), cardiac status (54), body mass index (61), serum albumin level (62), functional status (63), exercise limitation (63, 64) and co-morbidities (55).”
BackgroundPatel, N., DeCamp, M. M., & Criner, G. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200707-107et · Cited by 47
“The BODE (Body mass index, airflow Obstruction, Dyspnea, and Exercise capacity) index developed by Celli and coworkers combines four factors known to be associated with increased mortality in COPD: body mass index, the degree of airflow obstruction (percent predicted FEV1), dyspnea (modified Medical Research Council d…”
BackgroundMethodCourville, C. A., Tidwell, S., Liu, B., Accurso, F. J., Dransfield, M. T., & Rowe, S. M. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-25 · Cited by 43
“COPD severity was also measured by components of the BODE index (body mass index, obstruction (FEV1% predicted), and dyspnea (Modified Medical Research Council (MMRC) Questionnaire)) [19].”
MethodBiomarkers in the management of COPD
Lacoma, A., Prat, C., Andreo, F., & Domínguez, J. (2009) · European Respiratory Review · doi:10.1183/09059180.00000609 · Cited by 40
“One example is the BODE (body mass index, airway obstruction, dyspnoea and exercise tolerance) index, which has been recently been proposed to be a long-term prognosis marker for COPD patients [ 61 ].”
BackgroundPompeo, E., & Mineo, T. C. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.07.007 · Cited by 40
Fessler, D. M. T. (2002) · Ethos · doi:10.1525/eth.2002.30.1-2.25 · Cited by 39
Zhou, C., Qin, Y., Zhao, W. M., Liang, Z., Li, M., Liu, D., Bai, L., Chen, Y., Chen, Y., Cheng, Y. S., et al. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-339 · Cited by 44
“Another study (64) analyzed the prognoses different severities of COPD (mainly moderate-to-severe COPD) and found that 12% of the patients died of lung cancer.”
Qi, Q., Li, T., Li, J. C., & Li, Y. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154135 · Cited by 41
“BMI has served as an independent prognostic factor for chronic obstructive pulmonary disease (COPD), with a clear association between a low BMI and increased mortality (9).”
BackgroundThe 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?
Gruffydd‐Jones, K., & Loveridge, C. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00011 · Cited by 39
Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
Echave-Sustaeta, J. M., Casanova, L. C., Cosío, B. G., Soler‐Cataluña, J. J., Luján, R. G., & Ribera, X. (2014) · International Journal of COPD · doi:10.2147/copd.s71849 · Cited by 45
“This would be consistent with the idea that while FEV 1 is important for staging the disease itself, other factors are significant for determining disease prognosis.(34) We used the Charlson index as most of the studies, up to now.”
Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease.
Kim, V., Goel, N., Gangar, J., Zhao, H., CICCOLELLA, D. E., Silverman, E. K., Crapo, J. D., & Criner, G. J. (2014) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.1.2.2014.0133#sthash.pvwpnxai.dpuf · Cited by 42
Khadawardi, H. A., & Mura, M. (2016) · Respirology · doi:10.1111/resp.12945 · Cited by 40
Diaphragmatic Thickness Fraction in Subjects at High-Risk for COPD Exacerbations
Eryüksel, E., Çimşit, C., Bekir, M., Çimşit, Ç., & Karakurt, S. (2017) · Respiratory Care · doi:10.4187/respcare.05646 · Cited by 40
COPD Course and Comorbidities: Are There Gender Differences?
Grabicki, M., Kuźnar-Kamińska, B., Rubinsztajn, R., Brajer-Luftmann, B., Kosacka, M., Nowicka, A., Piorunek, T., Kostrzewska, M., Chazan, R., & Batura‐Gabryel, H. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_160 · Cited by 33
Rubio, M. C., Hermosa, J. L. R., Soler‐Cataluña, J. J., López-Campos, J. L., Navarrete, B. A., Soriano, J. B., González-Moro, J. M. R., Fuentes, M. E., & Miravitlles, M. (2018) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.11.015 · Cited by 41
“436 <0,001 0-2 701 (36,1) 492 (100) 3-4 772 (39,7) 5-6 379 (19,5) 7-9 92 (4,7)”
InfluentialPark, H. J., Cho, J., Kim, H. J., Park, J., Lee, H. S., & Byun, M. K. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12949 · Cited by 43
Swetz, K. M., & Kamal, A. H. (2018) · Annals of Internal Medicine · doi:10.7326/aitc201803060 · Cited by 40
Budweiser, S., Heidtkamp, F., Jörres, R. A., Heinemann, F., Arzt, M. E., Schroll, S., Schmidbauer, K., Hitzl, A. P., & Pfeifer, M. (2007) · Respiration · doi:10.1159/000109662 · Cited by 39
Rabahi, M. F., Junqueira‐Kipnis, A. P., de Moraes, M. R., Corrêa, K. D. S., & da Costa, A. C. (2014) · International Journal of COPD · doi:10.2147/copd.s64135 · Cited by 49
Metadata
- Authors
- Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J.
- Affiliations
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Hospital Clínico Universitario de Caracas (VE)
- Boston University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-04
- Volume
- 350
- Issue
- 10
- Pages
- 1005-1012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139347600
- Semantic Scholar
- 12606ed46f2e1cd6f56b679b445a8fda29690f65
- Cited by
- 4,015
- References
- 36
- Citations by year
- 2026: 88 · 2025: 115 · 2024: 153 · 2023: 132 · 2022: 124 · 2021: 176 · 2020: 199 · 2019: 158 · 2018: 192 · 2017: 184 · 2016: 206 · 2015: 185 · 2014: 241 · 2013: 230 · 2012: 242
- FWCI
- 135.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Keywords
- chronic obstructive pulmonary disease, BODE index, body mass index, airflow obstruction, dyspnea, exercise capacity, 6-minute walk test, mortality prediction, FEV1, disease severity classification, respiratory mortality
- MeSH terms
- Aged, Airway Obstruction, Dyspnea, Forced Expiratory Volume, Humans, Middle Aged, Prospective Studies, Risk, Risk Factors, Severity of Illness Index, Body Mass Index, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.